Chondromyxoid fibroma resembles in vitro chondrogenesis, by Bovée, J.V.M.G. et al.
Journal of Pathology
J Pathol 2005; 206: 135–142
Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/path.1782
Original Paper
Chondromyxoid fibroma resembles in vitro chondro-
genesis, but differs in expression of signalling molecules
Salvatore Romeo,1 Judith VMG Bovée,1 Shawn P Grogan,4 Antonie HM Taminiau,2 Paul HC Eilers,3
Anne Marie Cleton-Jansen,1 Pierre Mainil-Varlet4 and Pancras CW Hogendoorn1*
1Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands
2Department of Orthopaedic Surgery, Leiden University Medical Centre, Leiden, The Netherlands
3Department of Medical Statistics, Leiden University Medical Centre, Leiden, The Netherlands
4Osteoarticular Research Group, Bern University, Bern, Switzerland
*Correspondence to:
Pancras CW Hogendoorn,
Department of pathology, Leiden
University Medical Centre, PO




Received: 20 January 2005
Accepted: 13 March 2005
Abstract
Chondromyxoid fibroma is a rare benign cartilaginous bone tumour characterized by
morphological features that resemble different steps of chondrogenesis in terms of both
cellular morphology, ranging from spindled to rounded cells, and the extracellular matrix
formed, which ranges from fibrous to cartilaginous. The presence in chondromyxoid fibroma
of signalling molecules that regulate the spatial expression of proteins involved in normal
cartilage proliferation and differentiation was investigated in samples from 20 patients and
compared with articular chondrocytes from 11 normal donors cultivated in 3D pellet culture.
Sections were stained with safranin-O and H&E, and immunohistochemistry was performed
for p16, cyclin D1, FGFR3, BCL2, p21, PTHLH, PTHR1 and N-cadherin. Expression
patterns were analysed using hierarchical clustering. In chondromyxoid fibroma, specific
morphological features correlated with a distinct pattern of expression. Comparison with
normal chondrocytes in pellet culture showed a striking morphological resemblance, but
with an unmistakably different pattern of expression. N-cadherin, PTHLH, and PTHR1
were expressed to a significantly higher level (p < 0.01) in articular chondrocyte pellets but,
conversely, there was significantly lower expression of cyclin D1, p16 and BCL2 (p < 0.05) in
these cells. Morphological similarities reflect common steps in cartilage differentiation, albeit
driven by different molecular mechanisms. The proteins we have found to be differentially
expressed seem crucial for neoplastic chondrogenesis.
Copyright  2005 Pathological Society of Great Britain and Ireland. Published by John
Wiley & Sons, Ltd.
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Introduction
Chondromyxoid fibroma (CMF) is a benign cartilagi-
nous bone tumour with a polymorphous microscopic
appearance, as implicated by its name, ranging from
a chondroid to a myxoid and even fibrous pheno-
type [1,2]. It can affect almost every osseous site,
but is found more frequently in long (mainly prox-
imal tibia) and flat bones, the iliac bone being the
most frequent (∼25%) [1,3,4]. The distinct histolog-
ical features of CMF include lobules of spindle- or
stellate-shaped cells with abundant myxoid and chon-
droid extracellular matrix. Differences in extracellular
matrix appearance correspond to variation in proteo-
glycans and collagen composition, and in the morphol-
ogy of constituent cells [5]. The cellular areas and the
matrix-rich areas, the latter being classified as either
myxoid or chondroid, differ in the amount of type
I and II collagen and aggrecan. Generally, in cellu-
lar areas populated with predominantly spindle-shaped
cells, collagen type I is found [5], with no evidence of
the presence of collagen type II or aggrecan. Aggrecan
production, on the other hand, is evident in the myxoid
areas, where the cells display a stellate morphology.
Cells possessing rounded morphology and an extra-
cellular matrix morphology and biochemical make-up
similar to normal cartilage (presence of aggrecan and
collagen type II) characterize the chondroid regions
[5].
Morphologically, this spatial difference in cellu-
lar morphology and matrix distribution has a striking
parallel to the dynamic response of normal articular
chondrocytes placed into monolayer culture [6] and
subsequently maintained in various high-density cul-
ture systems [6,7] (Figure 1). Normal (non-neoplastic)
chondrocytes, cultured on standard plastic tissue cul-
ture flasks, undergo a well-documented process termed
dedifferentiation [6,8]. This transition is characterized
by loss of the rounded cell shape to a fibroblast-like
morphology and a shift in the proportion of aggrecan
(decreasing) and collagen expression (from type II to
type I) [9]. It is generally recognized that this process
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Figure 1. CMF resembles in vitro chondrogenesis. (a) Articular chondrocytes grown in flasks acquire a spindle shape
(dedifferentiation) but, when cultured in a 3D pellet system, the cells change shape and form several cell–cell and cell–extracellular
matrix interactions, finally forming extracellular matrix resembling mature cartilage. (b) Chondromyxoid fibroma resembles in vitro
chondrogenesis (a). The spindle cells at the periphery of the lobules resemble dedifferentiated chondrocytes morphologically (a).
The lobules of myxo-chondroid matrix are similar to the cartilage formed in vitro (a)
can be reversed (redifferentiation) under appropriate
conditions such as agarose [10], or in other three-
dimensional high-density cultures in the presence of
differentiation signalling molecules such as TGF-β
[9]. During this reverse process, the cells recover their
rounded morphology, reflected in a different pattern
of organization of the actin filaments. Moreover they
revert to expressing collagen type II, aggrecan and
other cartilage-specific genes [11,12], while signifi-
cantly reducing collagen type I production [12].
These processes include cell–cell and cell–extra-
cellular matrix interactions, mainly through integrins
and N-cadherin [12], specific extracellular matrix
deposition and differentiation toward cartilage forma-
tion, and are driven by several signalling molecules.
In particular, a key role is played by parathy-
roid hormone-related peptide (PTHLH) and fibroblast
growth factor (FGF), and cell cycle regulators, in
the regulation of cartilage growth in the epiphyseal
growth plate [13–15]. Furthermore, these signalling
molecules have been shown to be impaired in carti-
laginous tumours [16–18].
Based on morphological similarities between cells
and extracellular matrix, we hypothesized that the his-
tological features of CMF reflect different steps of
in vitro chondrogenesis: from dedifferentiated/spindle
shape cells to redifferentiated/round chondrocytes with
parallel production of either more fibrous or cartilagi-
nous matrix. To test this hypothesis, we performed
a comparative study of CMF with cultured articular
chondrocytes (dedifferentiated), which were pushed
towards redifferentiation through a 3D pellet culture
system. We investigated the morphological spectrum
of differentiation in combination with the expres-
sion pattern using immunohistochemistry for fibrob-
last growth factor receptor 3 (FGFR3), BCL2, p21,
PTHLH, parathyroid hormone-related peptide receptor
(PTHR1), cyclin D1, N-cadherin, and p16. This gen-
erated spatial information that allowed correlation of
the expression profile with the morphological features
of cells and extracellular matrix.
Methods
Pathological material
Twenty samples of CMF were selected from 18 pri-
mary and two recurrent tumours. The cases were
retrieved from the surgical pathology and consulta-
tion files of the Leiden University Medical Centre.
One primary tumour sample was kindly provided by
the Department of Pathology of Ghent University.
Formalin-fixed, formic acid (pH 2.1) decalcified and
paraffin-embedded archival tumour tissue was avail-
able for routine staining and immunohistochemical
analysis. All cases were examined following haema-
toxylin and eosin (H&E) staining to confirm the diag-
nosis and safranin-O staining to evaluate the amount
of sulphated proteoglycans in the extracellular matrix.
All specimens were handled according to the ethical
guidelines described in the Code for Proper Secondary
Use of Human Tissue in The Netherlands of the Dutch
Federation of Medical Scientific Societies.
Articular chondrocyte pellets (ACP)
As described in more detail elsewhere [19], cells were
isolated post mortem within 24 h after death from
the knee joints of a total of 11 normal donors who
specifically had no clinical history of joint disorders.
These donors were selected to be of matching gender
and age range. These procedures were performed in
J Pathol 2005; 206: 135–142
Chondromyxoid fibroma resembles in vitro chondrogenesis 137
accordance with the ethical guidelines of the Insti-
tute of Pathology, University of Bern. To create a
three-dimensional environment, 0.5 × 106 cells were
centrifuged at 250 g for 5 min in 1.5 ml polypropy-
lene conical tubes (Sarstedt, Nümbrecht, Germany) to
form a high-density pellet. The cell pellets were main-
tained in culture for 2 weeks in ITS+ media (Sigma
Chemical, St Louis, MO, USA), supplemented with
TGF-β1 and dexamethasone, at a final concentration
of 10 ng/ml and 39.25 µg/ml respectively [19]. Cell
morphology and the production of sulphated proteo-
glycans in the extracellular matrix were examined in
each pellet after 2 weeks using H&E and safranin-O
staining, respectively.
Immunohistochemistry
Immunohistochemical analysis was performed on
4 µm sections according to standard laboratory
procedures [17,18]. Details of antibodies and
antigen retrieval procedures used are listed in
Table 2. Briefly, after pre-treatment, sections were
incubated overnight with primary antibody, followed
by incubation in biotin-labelled rabbit anti-mouse
immunoglobulins and subsequent application of
biotinylated HRP–streptavidin complex application
(DAKO, Glostrup, Denmark). Visualization was
carried out in a diaminobenzidine solution (Sigma,
St Louis, MO, USA). The slides were counterstained
with haematoxylin. Appropriate positive control
slides were prepared according to each antibody
specificity (Table 1). Moreover, internal positive
controls (Table 1) were present in most of the
histological slides, allowing evaluation of the antigenic
property of the tissue after decalcification. As negative
controls, slides were incubated with mouse or rabbit
IgG of corresponding (iso-) types and concentration
instead of primary specific antibodies.
The specificities of these antibodies have been
validated previously and the expression levels were
compared to Q-PCR results [16].
Evaluation and criteria used for scoring
The immunostained slides were assessed and scored
by three pathologists independently (SR, JVMGB, and
PCWH) using the sum of intensity of signal (0 =
no expression, 1 = weak expression, 2 = moderate
expression, 3 = strong expression) and the number
of positive cells (% tumour cells: 0 = 0%; 1 =
1–25%; 2 = 26–50%, 3 = 51–75% 4 = 76–100%)
as described previously by us [18] and others [20]. The
three authors together, reaching a consensus, revised
discrepant scores. The above-mentioned scoring sys-
tem, emphasizing both staining intensity as well as
percentage of cells, has been shown to be highly repro-
ducible in our hands, and has also been used in pre-
vious studies on decalcified bone tumour specimens
[17,18].
The cellular areas and the matrix-rich areas were
evaluated separately if they constituted at least 10%
of the surface on the slide. A final weighted score,
adapted from Grogan et al [21], was calculated as
the sum of the scores of single areas multiplied by
the relative percentage extension of the area. The
mean value of the sum score was reported. Finally,
the cellular localization (nuclear, cytoplasmic, and
membranous) of immunopositivity was noted.
Statistical analysis
A paired, two-tailed t-test was applied in order to
evaluate significantly different distributions of final
sum score values between matrix-rich and cellular
areas in CMF.
An unpaired two-tailed t-test, unequal variance, was
applied in order to evaluate statistically significant dif-
ferences in the distribution of CMF’s final weighted
sum score values versus ACP’s final sum score. A
value of p < 0.05 was considered significant. All sta-
tistical analysis, if not otherwise specified, was per-
formed using the SPSS 10 software package. Cluster
analysis was carried out using the data of the sepa-
rate scores for intensity and the number of positive
cells. One case of CMF was discarded because of
too many absent values. The data were normalized,
mean-centred and the average linkage method was
applied by means of Cluster and TreeView programs
[22]. For similarity, metrics uncentred correlation was
used.
Table 1. Details of the antibodies and immunohistochemical protocols used







cyclin D1 Dako MC DCS6 Nuclear Tonsil Occasional endothelial cells 1 : 4000 mwo/10 min
p16 Neomarker MC 16 PO4 Nuclear Tonsil Keratinocytes/lymphocytes 1 : 100 mwo/0 min
FGFR3 Sigma PC Cytoplasmic Umbilical cord Striated muscle/blood vessel
walls/connective
tissue/osteoclasts
1 : 2000 Trypsin
p21 Calbiochem MC AB1 Nuclear Colon None 1 : 400 mwo/10 min
PTHLH Oncogene PC Cytoplasmic Skin None 1 : 200 Trypsin
PTHR1 Upstate MC 3d1.1 Cytoplasmic Skin Blood vessel walls/osteoblasts 11 : 100 mwo/10 min
BCL2 DAKO MC 124 Cytoplasm Tonsil Osteoblasts/lymphocytes 1 : 100 mwo/10 min
N-cadherin Transduction lab MC 32 Membranous/cytoplasmic Heart Nerves 1 : 100 mwo/10 min
PC, polyclonal; MC, monoclonal; FGFR3, fibroblast growth factor receptor-3; PTHLH, parathyroid hormone-related peptide; PTHR1, parathyroid
hormone-related peptide receptor; mwo, microwave oven.
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Results
Morphological and histochemical evaluation
Chondromyxoid fibroma
All the retrieved cases fitted the diagnostic criteria
for CMF, being formed by lobules of spindle- or
stellate-shaped cells with abundant myxoid and chon-
droid intercellular matrix [1,2]. In such lobules, a
zonal architecture could be recognized. The periph-
ery appeared to be cellular with a low amount of
extracellular matrix. Towards the centre of the lobules
there was more extracellular matrix with both myxoid
and chondroid features, the areas closer to the centre
being more similar to hyaline cartilage. The transi-
tion between cellular and matrix-rich areas was not
well demarcated, with the two areas gradually merg-
ing together. This was reflected in a gradual change
of cell shape, being slender in the cellular areas, stel-
late and triangular in the myxoid areas, and round in
the cartilage-like areas. Cells were large at the periph-
ery and smaller towards the centre. The location of
vessels also followed a zonal architecture, with vessel-
rich areas at the cellular periphery of the lobules and
absence of vessels in the central cartilage-like areas
(Figure 2B).
Articular chondrocyte pellet
The pellet samples showed similar morphology to
CMF in terms of both architectural pattern and cell
cytology. Rounded cells intermingled with stellate
cells were present in most of the pellets, together with
abundant extracellular matrix characterized by myxoid
and chondroid features. Spindle cells were present
mainly in a narrow area at the periphery just beneath
the surface (Figure 2E). A striking similarity between
the morphological features of spindle and stellate cells
of CMF and the articular chondrocytes cultivated in
monolayer was evident (Figure 2A, D). In both pellets
and CMF lobules safranin-O staining substantiated
the morphologically observed pattern. Areas with
intense glycosoaminoglycan staining were present at
the centre of the lobules of CMF and throughout the
ACP, while the peripheral areas showed no positive
stain at all (Figure 2C, F). Areas with weak staining
showed a myxoid appearance of the extracellular
matrix and contained stellate-shaped cells.
Immunohistochemical evaluation
The results are summarized in Table 2.
Chondromyxoid fibroma
In CMF cases the level of immunoreactivity was gen-
erally higher in the matrix-rich areas versus the cellular
areas, being significantly higher (p < 0.05) for p21,
cyclin D1, and PTHLH. For N-cadherin significantly
higher (p < 0.001) expression was observed in the cel-
lular areas (Figure 2G, H, I).
Articular chondrocyte pellet
The absence of staining for BCL2 in all ACPs was
noteworthy (Figure 2J). Due to the limited extent of
the cellular/peripheral areas (<10% of the surface
on the slide), it was not possible to score cellu-
lar/peripheral areas versus central/matrix rich areas
separately, as for CMF. Hence only a general score
was performed. The comparison between CMF and
pellets showed differences in expression: significantly
higher (p < 0.05) expression for p16, cyclin D1 and
BCL2 (Figure 2G, J) was found in CMF versus ACP,
with BCL2 being completely absent in ACP. Con-
versely, significantly higher (p < 0.05) expression of
N-cadherin (Figure 2I, L), PTHLH (Figure 2H, K) and
PTHR1 was found in ACP versus CMF. Generally the
statistical significance was the same assuming either
equal or unequal variance. The different patterns of
expression resulted in the two clusters visualized by
hierarchical clustering analysis (Figure 3).
Discussion
The morphological spectrum of CMF, in terms of both
the type of extracellular matrix produced and the resi-
dent neoplastic cells, is broader than what is normally
observed in normal mature hyaline cartilage. The












cyclin D1 2.6 ± 1.1 3.4 ± 1.1∗ <0.01† 3.2 ± 1∗ 1.9 ± 1.5 0.02†
p16 3.9 ± 1.3 4.1 ± 1.4 0.8 4.1 ± 1.3∗ 2.2 ± 1.2 <0.01†
FGFR3 6.7 ± 0.5 6.6 ± 0.6 0.3 6.7 ± 0.5 6.4 ± 1.1 0.5
p21 2.8 ± 1.1 3.4 ± 1.1∗ 0.04† 3.2 ± 1.1 3.2 ± 1.5 0.9
PTHLH 2.3 ± 1 4.3 ± 1.4∗ <0.001† 4 ± 1.4 6.8 ± 0.4∗ <0.001†
PTHR1 5.7 ± 1.1 5.5 ± 0.9 0.8 5.2 ± 1.6 6.5 ± 0.5∗ <0.01†
BCL2 3.1 ± 1.5 3.6 ± 1.5 0.3 3.6 ± 1.5∗ 0 ± 0.0 <0.001†
N-cadherin 5.3 ± 1.4 4.3 ± 1.3 <0.001† 4.9 ± 1 6.9 ± 0.3∗ <0.001†
Values are reported as mean sum score ± standard deviation, ∗ significantly higher mean sum score and
† significant p values.
CA, cellular areas; MA, matrix-rich areas; WS, weighted score.
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Figure 2. Morphological similarities between CMF and in vitro chondrogenesis (from A to F). Left column CMF, right column
articular chondrocytes. (A) Spindle and stellate cells in the myxoid areas of CMF (H&E stain 40×, original magnification);
(B) architectural organization of CMF lobules: vessels are present at the periphery (arrowhead), where cells are spindle-shaped
and there is little interposed extracellular matrix (cellular areas); more to the centre, the cells get rounder and extracellular matrix
is more abundant (matrix-rich areas) (H&E stain, 40× original magnification); (C) the architectural organization is substantiated
by the safranin-O staining pattern, which is negative in the cellular areas (arrowhead) but positive in the matrix-rich areas (*)
(20× original magnification); (D) articular chondrocytes grown in monolayer lose their round shape and become spindle-shaped
or stellate (inverted microscope, no stain, 40× original magnification); (E) articular chondrocytes cultivated in 3D pellets are
spindle-shaped at the periphery with little extracellular matrix but, more to the centre, the cells get rounder and extracellular
matrix is more abundant (H&E stain, 40× original magnification); (F) the extracellular matrix at the periphery of the pellet
is negative with the safranin-O stain (arrowhead), whereas at the centre, where the cells are rounder, it is positive (*)
(20× original magnification). Expression pattern in CMF and in vitro chondrogenesis (from G to L): left column CMF, right
column ACP; (G) BCL2 immunostaining is present in CMF and is greater in matrix-rich areas (m) compared with cellular areas (c);
(H) PTHLH immunostaining in CMF shows significantly higher expression in matrix-rich (m) versus cellular (c) areas; (I) N-cadherin
immunostaining in CMF shows significantly higher expression in cellular (c) than in matrix-rich (m) areas; (J) BCL2 immunostaining
is absent in ACP; (K) PTHLH immunostaining in ACP shows significantly higher expression than CMF (40× original magnification);
(L) N-cadherin immunostaining in ACP shows significantly higher expression than CMF (40× original magnification)
morphological features observed are suggestive of the
recapitulation of in vitro chondrogenesis, and this has
prompted us to study the phenotype of the neoplastic
cells, the specific extracellular matrix present, and their
relative profile of expression of different molecules
known to be involved in cartilage differentiation. Our
study shows that the expression of these regulators
of cartilage differentiation and cell cycle regulatory
molecules differs significantly in cellular areas versus
matrix-rich areas of CMF. Most of the tested pro-
teins were expressed more extensively and intensely
in the matrix-rich areas. This could reflect the role of
J Pathol 2005; 206: 135–142
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Figure 3. Hierarchical clustering. Two different clusters are evident from the tree in the upper part of the figure. On the left are
the articular chondrocytes (ac) and on the right the cases of chondromyxoid fibroma (cmf). In the rest of the figure (heat map), as
exemplified by the bar on the right side, the green-coloured blocks represent low values and the red-coloured blocks high values
of the proteins studied (I, intensity; P, percentage). The colours in between are intermediate, with black being the mean value;
grey blocks represent missing data. #, proteins significantly higher in pellet; *, proteins significantly higher in CMF
these molecules in promoting both the deposition of
abundant specific extracellular matrix and the typical
cellular phenotype of the resident cells. Conversely,
N-cadherin expression was significantly higher in the
cellular areas. This pattern strictly resembles the ini-
tial mesenchymal condensation in which N-cadherin
is present only in undifferentiated precursor chondro-
cytes and is lost after developing the phenotype of
differentiated chondrocytes [12,23]. In this respect the
higher expression of N-cadherin in the cellular areas
may reflect a role for the homophilic cellular inter-
actions in the commitment of undifferentiated cells
towards chondrogenesis, later occurring more towards
the centre of the lobule, or conversely in the mainte-
nance of the less differentiated phenotype characteris-
tic of the cellular areas.
We have used an in vitro system as a compara-
tive model since we observed a striking morphologi-
cal resemblance between CMF and cultured articular
chondrocytes. In particular, the zonal architecture of
CMF lobules strictly resembled that in chondrocyte
pellets. A gradient of oxygen and nutrients may be
responsible for this architecture since, in both CMF
lobules and ACP, these have to diffuse from the
periphery towards the centre through the extracellu-
lar matrix. The degree of differentiation of cultured
chondrocytes has been shown to be inversely propor-
tional to oxygen tension [24]. Consistent with this,
a rounder morphology of cells together with intense
safranin-O staining, reflecting the phenotype of differ-
entiated chondrocytes, was seen in the central areas of
the chondrocyte pellet and in the matrix-rich areas of
CMF lobules, where the oxygen tension is expected to
be lower. Despite their striking morphological resem-
blance, CMF and chondrocyte pellets showed different
expression patterns (Figure 3). In particular, expres-
sion of PTHLH and PTHR1 was significantly higher
in the chondrocyte pellet culture system. This could
be the result of culture conditions promoting chon-
drogenesis, since the media used include high levels
of TGF-β (10 ng/ml). It is well known that this sig-
nalling molecule can induce, specifically in articular
chondrocytes, upregulation of PTHLH [25]. However,
it is also known that, in vivo, PTHLH binding to its
receptor PTHR1 leads to the upregulation of BCL2
in proliferative and pre-hypertrophic chondrocytes of
the growth plate [26]. Such an effect is not present
in vitro in the absence of extra doses of PTHLH [26].
In this regard our results with pellets resembled the
results of previous experiments [26], since chondro-
cytes cultured in a high-density system, in the absence
of supplemented extra dose of PTHLH, do not express
BCL2.
The diffuse positive signal for BCL2 in CMF is
noteworthy, especially considering its lower level of
PTHLH. This striking difference in BCL2 expres-
sion between CMF and normal chondrocytes cul-
tured in vitro indicates a different mechanism of sig-
nalling/transduction that may be due to the effect of
other mediators present in vivo and not in vitro [26],
or the result of differences in cartilage differentiation
in neoplasia versus normal cells.
An intriguing result was the different levels of
expression found for p16 and cyclin D1. These
two molecules counteract one another in regulating
cell cycle progression. The cyclin D/cyclin-dependent
J Pathol 2005; 206: 135–142
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kinase (cdk) 4/6 complex phosphorylates Rb (retino-
blastoma) proteins, promoting progression of the cell
cycle [27]. This action is counterbalanced by the bind-
ing of p16 to the complex, which in turn induces an
allosteric change in cdk4/6, thereby altering the bind-
ing site of D-type cyclins and reducing its affinity for
ATP, hence inhibiting cell cycle progression [27]. The
presence of both counteracting proteins is in agree-
ment with the clinically benign nature of CMF. In a
previous study [28] the expression of p16 in enchon-
dromas and loss of expression in conventional chon-
drosarcomas was observed, which illustrates the role
of this molecule in balancing proliferative activity typ-
ical of malignant transformation. The lower level of
cyclin D1 in ACPs is of note, considering their higher
level of PTHLH and their stimulation by external
TGF-β, both known to upregulate cyclin D1 expres-
sion [29]. Again this result underlines the difference in
signalling/transduction mechanisms between in vitro
chondrogenesis and CMF, despite their histological
similarities. The difference in N-cadherin expression in
CMF versus ACP reflects differences in spatial distri-
bution: the expression in CMF is higher in the cellular
areas, while in ACP it is largely expressed where cells
are embedded in abundant extracellular matrix. Since
the ACPs were cultured for only 2 weeks, N-cadherin
may still be present at a high level as the condensation
phase is perhaps still going through its end stages. FGF
signalling is conserved in CMF and ACP, since the
expression of FGFR3 and p21 does not differ signif-
icantly between them. Both molecules are part of the
FGF signalling pathways in which, in chondrocytes,
p21 is the downstream molecule of FGFR3 activation,
resulting in inhibition of cell cycle progression and
indirectly promoting differentiation [13].
Comparison between in vitro and in vivo conditions
is in general problematic. Although the in vitro results
in the present study have been obtained under the
influence of TGF-β1, the possible influence of this
condition has been discussed above. Furthermore,
recent data showed a diffuse presence of functionally
active TGF-β1 in CMF [30].
In conclusion, we have clearly identified and sub-
stantiated the morphological similarities between CMF
and in vitro cell culture chondrogenesis. Similarities
include cellular morphology, quality of the extracel-
lular matrix and cytoarchitecture. In our opinion this
clearly reflects conservation of the basic process of
cartilage formation in this neoplastic condition, fur-
ther confirmed by the expression of PTHLH as well
as FGF signalling molecules. The observed differ-
ence in expression of these molecules, between the
matrix-rich areas versus the cellular areas of CMF,
may reflect their importance in the commitment of
neoplastic cells toward cartilage differentiation. The
comparisons with ACP showed significantly higher
expression of N-cadherin, PTHLH and PTHR1 and,
conversely, lower expression of cyclin D1and p16 in
ACP versus CMF. The absence of BCL2 expression
in ACP is noteworthy. These differences in expression
may be crucial in neoplastic chondrogenesis.
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